Investigators Highlight Disparities Evident in Skin Disease Care, Data Collection
March 19th 2023Posters presented at the American Academy of Dermatology 2023 Annual Meeting provided a snapshot of disparities in dermatology care, both in terms of geographic differences in access to care and collection of race/ethnicity data in clinical trials.
Chatbot Systems Using AI May Feasibly Provide Access to Information on Infectious Diseases
March 19th 2023A recent study found that chatbot systems that used artificial intelligence (AI) could be valuable in providing access to current, accurate, and complete information about infectious diseases and vaccines against them.
Drs Dellavalle and Rodriguez Discuss Disparities in Prescription Patterns for Atopic Dermatitis
March 19th 2023Using the DataDerm database has uncovered disparities in prescription patterns, but it’s still early in the process of understanding why those disparities might exist, said Robert Dellavalle, MD, PhD, MSPH, and Ramiro Rodriguez, MD, both of University of Colorado School of Medicine.
Study Underscores Need for Optimal RV Function Measures in PH
March 18th 2023Right ventricular (RV) dysfunction has previously been linked to symptoms and mortality in pulmonary hypertension (PH), as well as in other conditions, and RV function plays an important role in disease risk and potentially in intensification of pulmonary arterial hypertension treatment.
Late-Breaking Abstracts Demonstrate Value of Persistence With Ruxolitinib Cream for Vitiligo
March 18th 2023Amid a packed roster of of late-breaking research at the American Academy of Dermatology 2023 Annual Meeting, investigators presented findings from long-term extensions of the Topical Ruxolitinib Evaluation in Vitiligo phase 3 studies.
Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of Care
March 18th 2023Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to care in the first place.
Prostate Cancer Deaths in PSA-Detected Disease Remained Low at 15 Years
Extended follow-up data from the ProtecT trial highlight the importance of weighing the risks associated with radical treatment versus active surveillance for newly diagnosed localized prostate cancer.
Patients With AD May Have Greater Risk of Certain Malignancies
March 17th 2023Investigators of this study noted the need for more data on risks of malignancies among patients who have atopic dermatitis (AD), with the chronic skin condition already having significant associations with nonmelanoma skin cancer, lymphoma, keratinocyte carcinoma, and pancreatic and kidney cancers.